Mississippi HB856 removes repealer on prohibition against health plans requiring step therapy for advanced, metastatic cancer drugs.
Mississippi HB856 reenacts provisions that prohibit health benefit plans from requiring step therapy or fail-first protocols before covering certain prescription drugs for advanced, metastatic cancer and associated conditions. The bill also outlines the process for prescribing practitioners to request an override of insurer restrictions on medication. The act takes effect from and after June 30, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.